Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
Rang in aandelen #17926
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
Aandeelprijs
$18.20
Laatst gesynchroniseerd: 2025-05-09
Marktkapitalisatie
$220.35M
Verandering (1 dag)
-5.34%
Verandering (1 jaar)
0.00%
Land
JP
Handel I'rom Group Co., Ltd. (2372)

Categorie

Winst voor I'rom Group Co., Ltd. (2372)
Winst in Dec 2024 TTM: $9.98M
Volgens de meest recente financiële verslagen van I'rom Group Co., Ltd. bedraagt de huidige winst van het bedrijf $9.98M. In 2023 behaalde het bedrijf een winst van $25.17M, een stijging ten opzichte van de winst van 2022, die $21.24M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van I'rom Group Co., Ltd. van 2005 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $9.98M -23.16%
2024 $12.99M -48.39%
2023 $25.17M 18.51%
2022 $21.24M 39.44%
2021 $15.23M 45.30%
2020 $10.48M -1.23%
2019 $10.61M -38.18%
2018 $17.17M 595.33%
2017 $2.47M -134.25%
2016 $-7.21M 43.61%
2015 $-5.02M 55.00%
2014 $-3.24M -117.10%
2013 $18.94M -1,247.10%
2012 $-1.65M -227.92%
2011 $1.29M -117.79%
2010 $-7.26M -93.02%
2009 $-104.01M 912.86%
2008 $-10.27M 79.68%
2007 $-5.72M -184.52%
2006 $6.76M -56.10%
2005 $15.40M 0.00%
Winst van vergelijkbare bedrijven of concurrenten